This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Danforth, D. N. Articles by Sgagias, M. K. Search for Related Content PubMed PubMed Citation Articles by Danforth, D. N., Jr. Articles by Sgagias, M. K.

Interleukin-1 and Interleukin-6 Act Additively to Inhibit Growth of MCF-7 Breast Cancer Cells in Vitro¹

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

We studied the effects of interleukin-1 (IL-1) and interleukin-6 (IL-6) on MCF-7 breast cancer cells to determine whether these cytokines act additively/synergistically to alter cell growth and metabolism. We found that IL-1 alone (1000 units/ml) inhibited cell growth to a greater degree (83.8%) than IL-6 alone (29.2%, P < 0.001). The combination of IL-1 + IL-6 caused greater inhibition of growth (92.9%, P < 0.02) than either cytokine alone. The additive effect was dose dependent for both IL-1 and IL-6. IL-1 and IL-6 also antagonized estradiol (10^-9 M) stimulated growth. Antagonism by the combination was greater than for either cytokine alone (P < 0.001). IL-1 or IL-6 alone each down-regulated the estrogen receptor (36.7%, P < 0.01, and 23.2%, P < 0.05, respectively), but the combination IL-1 + IL-6 did not cause a significantly greater effect than IL-1 alone. Neither IL-1 or IL-6 blocked estradiol stimulation of progesterone receptor (PR) synthesis; however, the combination IL-1 + IL-6 increased PR content by 28.4% (P < 0.01). IL-1, but not IL-6, increased secretion of transforming growth factor-ß (TGF-ß) by 2.45-fold over 72 h (P < 0.01). The increase was time dependent (detectable at 24 h) and dose dependent (maximum increase of 5.3-fold, 10,000 units/ml, P < 0.02). IL-1-induced TGF-ß secretion was blocked by estradiol (10^-9 M). Neither cytokine altered secretion of insulin-like growth factor-1. These findings indicate that IL-1 and IL-6 act additively to inhibit growth in the absence or presence of estradiol and modulate the estrogen receptor and progesterone receptor content of these cells. TGF-ß may mediate the effects of IL-1; however, other pathways appear to be required for the additive effects of these cytokines.

¹ Presented at the 83rd Annual Meeting, American Association for Cancer Research, San Diego, CA, May 20, 1992.

² To whom requests for reprints should be addressed, at Surgery Branch, NCI, Bldg 10, Rm 2B38, Bethesda, Maryland 20892.

Received 6/16/92. Accepted 1/22/93.

This article has been cited by other articles:

				L. A. Hefler, C. Grimm, T. Lantzsch, D. Lampe, S. Leodolter, H. Koelbl, G. Heinze, A. Reinthaller, D. Tong-Cacsire, C. Tempfer, et al. Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women Clin. Cancer Res., August 15, 2005; 11(16): 5718 - 5721. [Abstract] [Full Text] [PDF]

				C. F. Singer, N. Kronsteiner, G. Hudelist, E. Marton, I. Walter, M. Kubista, K. Czerwenka, M. Schreiber, M. Seifert, and E. Kubista Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: Interleukin 1{alpha} Protein Secretion Is Correlated with Malignant Phenotype Clin. Cancer Res., October 15, 2003; 9(13): 4877 - 4883. [Abstract] [Full Text] [PDF]

				W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor Cancer Res., August 15, 2002; 62(16): 4746 - 4756. [Abstract] [Full Text] [PDF]

				J. M. Zmuda, J. A. Cauley, B.-M. Ljung, D. C. Bauer, S. R. Cummings, and L. H. Kuller Bone Mass and Breast Cancer Risk in Older Women: Differences by Stage at Diagnosis J Natl Cancer Inst, June 20, 2001; 93(12): 930 - 936. [Abstract] [Full Text] [PDF]

				A. Spyridonidis, W. Bernhardt, D. Behringer, G. Kohler, M. Azemar, A. Pflug, and R. Henschler Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells Blood, January 15, 1999; 93(2): 746 - 755. [Abstract] [Full Text] [PDF]

				S. Gingras, R. Moriggl, B. Groner, and J. Simard Induction of 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Type 1 Gene Transcription in Human Breast Cancer Cell Lines and in Normal Mammary Epithelial Cells by Interleukin-4 and Interleukin-13 Mol. Endocrinol., January 1, 1999; 13(1): 66 - 81. [Abstract] [Full Text]